Abstract:Abstract BACKGROUND AND AIMS Kidney disease is associated with a huge economic burden. High-income countries spend up to 2%–3% of their annual health care budget on end-stage kidney disease. Even if <0.03% of the total population receive such treatment. In 2010, 2.62 million people worldwide received dialysis, and the demand for dialysis is projected to double by 2030. The most common cause of death in patients with CKD is complications from cardiovascular disease. They are the main factor determining the decrease in the effectiveness of renal replacement therapy, especially among young and middle-aged people. Mortality from cardiovascular disease in people with end-stage CKD is 10–30 times higher than in the general population. Purpose of the work: to comparatively study the survival rates in dialysis patients, depending on the presence of cardiovascular diseases. METHOD In our study, we conducted a prospective cohort study of 210 patients (117 men and 93 women) in three different dialysis centers in Uzbekistan. The study lasted 36 months (from January 2018 to December 2020). The average age was 49.2 ± 13.8 years. The main primary diseases were glomerulonephritis (44%), diabetes mellitus (29%) and urolithiasis (7%). The duration of hemodialysis at the time of enrollment of patients in the study ranged from 6 to 172 months. Among the examined dialysis patients, 53% (n = 112) of patients (62 men and 50 women) had CVD and 47% (n = 98) of patients (52 men and 46 women) had no CVD. The main CVDs were arterial hypertension, ischemic heart disease, heart failure and various arrhythmias. Survival was determined by the Kaplan–Meier method. The [95% confidence interval (95% CI)] was determined using the Greenwood method. RESULTS After 36 months of follow-up, 43.8% (n = 92) of all patients died, 56.2% (n = 118) of patients survived (17 of them underwent kidney transplantation). When analyzing the causes of mortality, the main causes of death in dialysis patients were sudden cardiac death, acute respiratory failure, acute cerebrovascular accident, coma and acute bleeding. In dialysis patients with CVD, sudden cardiac death was 67% (n = 42) of all causes of death, while in patients without CVD, it was 57% (n = 17). The average age of the deceased (54.2 ± 1.4) was significantly higher than in patients continuing to receive HD (44.3 ± 1.1). The average duration of hemodialysis in the survivors (34.1 ± 4.7) was higher than in the deceased (27.6 ± 2.8). Upon further analysis of these patients, it was found that among the deceased patients, 70.6% (n = 65) of the patients were patients with cardiovascular diseases, and among the survivors, 54.3% (n = 64) had no cardiovascular diseases. Among those continuing to receive dialysis, there were 32.6% more patients without CVD than among patients with diagnosed CVD. In dialysis patients with CVD who died within 36 months of prospective follow-up, there were 38.7% more deaths than in patients without CVD. The survival rate of patients with CVD was 0.44 (95% CI 0.33–0.51), and in patients without CVD it was 0.65 (95% CI 0.52–0.74). CONCLUSION Our scientific research has shown that >70% of dialysis patients with CKD die due to cardiovascular disease. The main place in the structure of mortality is taken by sudden cardiac death, which is the cause of death in 67% of deceased patients. Cardiovascular comorbidity adversely affects the survival of dialysis patients in Uzbekistan. In dialysis patients without cardiovascular disease in our country, the survival rate is >30% higher than in patients with CVD.

The Impact of Diabetes Mellitus and Hypertension As Comorbidon Survival Rate Chronic Kidney Disease on Chronic Hemodialysis Patients (INDONESIAN RENAL REGISTRY REPORT ANALYSIS 2007–2012)

Comparison of Peritoneal Dialysis with Hemodialysis on Survival of Diabetic Patients with End-Stage Kidney Disease: a Meta-Analysis of Cohort Studies

MO832: Survival of Dialysis Patients With Cardiovascular Comorbidity

Survival Rate and Associated Risk Factors Among Hemodialysis Patients in Southwest Iran: A Retrospective Cohort Study

Five-year survival analysis and predictors of mortality of adult hemodialysis patients in Indonesia: a nationwide database analysis

Prognostic Analysis of Aged End-Stage Renal Disease Patients Receiving Hemodialysis and Peritoneal Dialysis

A comparative study of the prognosis in end-stage diabetic kidney disease patients treated with hemodialysis and those treated with peritoneal dialysis

The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview

MO902: Age-Specific Impacts of Risk Factors on All-Cause Mortality in Dialysis Patients

Factors influencing long-term survival in patients on chronic dialysis

1-8DIAGNOSTIC VALUE OF HEMOGLOBIN LEVELS, UREA REDUCTION RATIO AND Kt/V IN DETECTING INTRADIALYTIC HYPERTENSION IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS AT SANGLAH HOSPITAL DENPASAR

Long-term Survival Rate of Maintenance Hemodialysis Patient with Diabetic Nephropathy

Long-term outcomes of peritoneal dialysis patients with diabetes as a comorbid condition

Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis

1-7PROFILE OF HYPERTENSION IN HEMODIALYSIS PATIENTS IN CIKINI CCI HOSPITAL: A DESCRIPTIVE STUDY

Comparison Of Long-Term Outcomes Between Peritoneal Dialysis Patients With Diabetes As A Primary Renal Disease Or As A Comorbid Condition

Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea

Diabetes and mortality among patients with chronic kidney disease and COVID-19: A systematic review, meta-analysis, and meta-regression

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study

A16804 Pulmonary hypertension increases the risk of all-cause mortality in dialysis patients: Evidence-based meta-analysis using real world data

Burden of Pulmonary Hypertension in End-Stage Renal Disease Patients Receiving Maintenance Hemodialysis: Evaluation Factors and Treatment Strategies